Risk of new-onset urinary incontinence 3 and 12 months after vaginal or cesarean delivery of twins: Part I.


Journal

International urogynecology journal
ISSN: 1433-3023
Titre abrégé: Int Urogynecol J
Pays: England
ID NLM: 101567041

Informations de publication

Date de publication:
06 2019
Historique:
received: 24 07 2018
accepted: 18 09 2018
pubmed: 8 10 2018
medline: 6 2 2020
entrez: 8 10 2018
Statut: ppublish

Résumé

Our purpose was to compare the prevalence of urinary incontinence (UI) 3 and 12 months after vaginal vs cesarean delivery of twins after 34 weeks of gestation. This was a multicenter prospective cohort study conducted at 172 French maternity units and included 2812 primiparous women with twins with no prior history of UI. Participants were enrolled at the time of delivery and followed up to 12 months postpartum. The primary outcome was the prevalence of UI, both stress and urge, 3 months postpartum, based on the patient reporting any frequency of urine leakage to the first question of the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF). The Pelvic Floor Distress Inventory - Short Form 20 (PFDI-20), Pelvic Floor Impact Questionnaire - Short Form 7 (PFIQ-7), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12), and Medical Outcome Study Short Form-12 (SF-12) were also used. The ICIQ-SF was completed by 1155 (39.8%) and 800 (27.5%) women, respectively, at 3 and 12 months postpartum; 556 (48%) had delivered vaginally and 599 (52%) by cesarean section. The prevalence of UI at 3 months was 26% overall and was significantly higher in the vaginal delivery group at both 3 months (35% vs 17% in the cesarean group, p < 0.0001) and 12 months postpartum (38% vs 24%, p < 0.0001). UI was predominantly stress or mixed. The risk factors for UI at 3 months, determined by multivariate modeling, were vaginal delivery [odds ratio (OR) 3.073, 95% confidence interval (CI) 2.3-4.105, p < 0.0001) and body mass index >25 in early pregnancy (OR 1.620, 95% CI 1.188-2.209, p = 0.0023). Vaginal delivery is a risk factor for UI at 3 months after twin birth.

Identifiants

pubmed: 30293167
doi: 10.1007/s00192-018-3774-4
pii: 10.1007/s00192-018-3774-4
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

881-891

Références

Obstet Gynecol. 2017 Jun;129(6):986-995
pubmed: 28486364
J Gynecol Obstet Biol Reprod (Paris). 2009 Dec;38(8 Suppl):S146-52
pubmed: 20141913
Int Urogynecol J. 2018 Dec;29(12):1807-1815
pubmed: 29582089
J Gynecol Obstet Biol Reprod (Paris). 2007 Dec;36(8):738-48
pubmed: 17881153
Gynecol Obstet Fertil. 2010 Apr;38(4):238-43
pubmed: 20362483
BJOG. 2006 Feb;113(2):218-24
pubmed: 16412001
BJOG. 2006 May;113(5):528-35
pubmed: 16637897
Neurourol Urodyn. 2017 Aug;36(6):1519-1528
pubmed: 27701779
Am J Obstet Gynecol. 2001 Jul;185(1):82-7
pubmed: 11483909
BJOG. 2013 Nov;120(12):1548-55
pubmed: 23786421
Br J Obstet Gynaecol. 1996 Feb;103(2):154-61
pubmed: 8616133
BMJ. 2011 Nov 23;343:d7108
pubmed: 22113566
J Gynecol Obstet Biol Reprod (Paris). 2010 Dec;39(8 Suppl 2):S139, S338-42
pubmed: 21229670
Obstet Gynecol. 2001 Mar;97(3):350-6
pubmed: 11239635
Eur J Obstet Gynecol Reprod Biol. 2016 May;200:35-9
pubmed: 26967344
Int Urogynecol J. 2015 Aug;26(8):1115-21
pubmed: 25708677
Neurourol Urodyn. 2004;23(4):322-30
pubmed: 15227649
Obstet Gynecol. 2003 Dec;102(6):1291-8
pubmed: 14662217
J Gynecol Obstet Biol Reprod (Paris). 2009 Dec;38(8):662-7
pubmed: 19837520
BJOG. 2018 Dec;125(13):1682-1690
pubmed: 30007113
BJOG. 2015 Nov;122(12):1653-62
pubmed: 26328526
Eur Urol. 1999 Sep;36(3):165-74
pubmed: 10449997
N Engl J Med. 2013 Dec 5;369(23):2218-25
pubmed: 24304051
BJOG. 2016 May;123(6):1022-9
pubmed: 25846816
BJOG. 2006 Feb;113(2):208-17
pubmed: 16412000

Auteurs

Renaud de Tayrac (R)

Department of Obstetrics and Gynecology, Carémeau University Hospital, Nîmes, France. renaud.detayrac@chu-nimes.fr.
Obs/Gyne Dept, Nimes University Horpital, Place du Prof Debre, 30900, Nîmes, France. renaud.detayrac@chu-nimes.fr.

Fanny Béchard (F)

Department of Obstetrics and Gynecology, Carémeau University Hospital, Nîmes, France.

Christel Castelli (C)

Department of Biostatistics, Epidemiology, Public Health and Medical Information (BESPIM), Nîmes University Hospital, Nîmes, France.

Sandrine Alonso (S)

Department of Biostatistics, Epidemiology, Public Health and Medical Information (BESPIM), Nîmes University Hospital, Nîmes, France.

Emmanuelle Vintejoux (E)

Department of Obstetrics and Gynecology, Arnaud de Villeneuve University Hospital, Montpellier, France.

François Goffinet (F)

INSERM UMR 1153, Obstetrical, Perinatal and Pediatric Epidemiology Research Team (EPOPé), Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), DHU Risks in Pregnancy, Paris Descartes University, Paris, France.

Vincent Letouzey (V)

Department of Obstetrics and Gynecology, Carémeau University Hospital, Nîmes, France.

Thomas Schmitz (T)

Department of Obstetrics and Gynecology, Robert Debré University Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH